Ireland’s Cell and Gene Therapy Map: Illuminating the Island’s Growing Ecosystem
Introduction
Last week’s launch of the Irish Society for Gene and Cell Therapy (ISGCT) website marked a milestone in building visibility for advanced therapies across the island of Ireland. It comes at a time when Ireland’s ecosystem - spanning research, clinical delivery, and manufacturing - is accelerating rapidly.
At Lonrú Consulting, we see this as the right moment to shine a light on the opportunities Ireland presents for enabling technology providers. To make this landscape more tangible, we’ve built a new resource: Ireland’s Cell and Gene Therapy Map - an interactive tool that brings the island’s ecosystem into focus.
Ireland’s Cell and Gene Therapy Map
Ireland’s Cell and Gene Therapy Map is a first-of-its-kind interactive ecosystem map showcasing:
Research centers advancing discovery and translational science.
Clinical sites delivering stem cell transplants and CAR-T therapies.
Manufacturing facilities producing GMP-grade advanced therapy products.
Key players and consortia driving collaboration and innovation.
Explore the interactive map below.
The tool enables users to click through academic hubs, GMP facilities, consortia, and companies, discovering why each node matters for tool providers. Filters make it easy to focus on capabilities such as GMP, analytics, non-viral delivery, or clinical trial readiness.
Why It Matters for Enabling Technology Providers
The map demonstrates that Ireland offers more than clinical delivery or traditional biopharma manufacturing. From Takeda’s stem cell manufacturing facility in Dublin, to CCMI’s GMP-licensed ATMP site in Galway, to St. James’s CAR-T program, and HiTech Health’s new CDMO capacity, Ireland is becoming a proving ground for enabling technologies.
For providers of analytics, automation, delivery platforms, and quality systems, Ireland is a place to:
Pilot tools with translational centers and GMP labs.
Validate technologies in live manufacturing and clinical environments.
Partner with consortia like ISGCT and Can-Vas to link into funding and clinical trials.
Lonrú’s Perspective
With Ireland’s Cell and Gene Therapy Map, we’ve built a resource that not only catalogs facilities, but highlights why each node matters for tool and platform providers.
This aligns with our ethos: Navigating complexity, illuminating innovation. By combining insights, interactivity, and data-driven clarity, we aim to help enabling technology providers see Ireland’s position in the global CGT landscape.
Looking Ahead
With the relaunch of ISGCT and the launch of our interactive map tool providers can see that Ireland is ready to step forward as a connected hub for cell and gene therapy.
For enabling technology providers, the opportunity is clear: engage early, validate locally, and scale globally.
